This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.
Age: 0 - 18 years
Gender: All
We've found 2 total result s for "Hyperparathyroidism".
Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Neoplasm Metastasis
- Kidney Diseases
- Renal Insufficiency, Chronic
- Hyperparathyroidism
- Hyperparathyroidism, Secondary
Age: Birth - 18 years
Gender: All